The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
about
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem CellsBrother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer.The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancerBORIS/CTCFL is an RNA-binding protein that associates with polysomes.Age- and pregnancy-associated DNA methylation changes in mammary epithelial cells.The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanismsEpigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation.The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivoExpression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states.ASCT2 regulates glutamine uptake and cell growth in endometrial carcinomaLAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.Expression of the cancer-testis antigen BORIS correlates with prostate cancer.CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic.Depletion of CTCF in Breast Cancer Cells Selectively Induces Cancer Cell Death via p53.CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity.Functional roles of CTCF in breast cancer.The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.CCCTC-binding factor inhibits breast cancer cell proliferation and metastasis via inactivation of the nuclear factor-kappaB pathway.Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions.BORIS: a key regulator of cancer stemness
P2860
Q28546641-A2AA1FD1-9D0A-4DED-A5A5-0F3386BEF2C2Q30354418-DE0AD0DE-68E9-4F20-AF5B-3779777CD184Q34088277-253F5FB4-EFD8-47E8-9669-019AD3FC4E49Q35054487-DB9A55EC-5574-4C1C-88C8-F21BCDF225BEQ35075323-746D5661-912C-4728-922D-FAD2F3E281DEQ35911372-2EE05727-7DE7-49C4-B833-A79BD58759A9Q35959917-F0FA4895-7AEF-4EC3-9325-ECEFC6D5F376Q36427088-2E248B6A-36B6-41E8-9DA1-925D63D1D836Q37727031-48920A7D-4E2F-4FC8-9604-69A724087D59Q38306384-DAF3553B-802C-4694-86B5-327A932F1DDBQ38651973-BADA02C3-8FC2-435E-A5F1-8C19EF74ED9DQ38754089-5DB84E1E-5AFC-49AE-971E-218A58D8C292Q39079438-9D3AF7AD-3380-45DC-AEF7-1B174CDED1F2Q41073866-C80D9348-1902-4C23-8039-E9402C2051DDQ41439955-E1682202-4E5D-40C1-8EDA-29CDF070D187Q42266332-B5AD4938-A8BA-4DBC-9B5A-E1FBC2CB4CD4Q42369328-C29D31EC-9D31-4915-988A-C8F75425E2E5Q42961773-1132A29F-A0ED-4931-913F-CACCD1ACF135Q47136706-2AA51247-EF22-4305-8C9E-8937685517BAQ53762384-E62A2904-1D72-493B-97EE-59F5337193C2Q57482782-36629F09-D8AB-4D9A-A776-8704808C11A0
P2860
The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The cancer-testis antigen BORI ...... n normal and neoplastic cells.
@en
The cancer-testis antigen BORI ...... n normal and neoplastic cells.
@nl
type
label
The cancer-testis antigen BORI ...... n normal and neoplastic cells.
@en
The cancer-testis antigen BORI ...... n normal and neoplastic cells.
@nl
prefLabel
The cancer-testis antigen BORI ...... n normal and neoplastic cells.
@en
The cancer-testis antigen BORI ...... n normal and neoplastic cells.
@nl
P2093
P2860
P50
P356
P1476
The cancer-testis antigen BORI ...... in normal and neoplastic cells
@en
P2093
Cynthia Metierre
Jessamy C Tiffen
John E J Rasko
Sarah L Watson
P2860
P304
P356
10.1002/IJC.28184
P577
2013-05-02T00:00:00Z